Development of Orally Disintegrating Tablets of Standardized Rhodiola rosea Extract.

IF 4.8 3区 医学 Q2 CHEMISTRY, MEDICINAL
Pharmaceuticals Pub Date : 2025-09-04 DOI:10.3390/ph18091328
Oxana Brante, Rihards Talivaldis Bagons, Santa Niedra, Austris Mazurs, Baiba Mauriņa, Jurga Bernatoniene, Konstantins Logviss
{"title":"Development of Orally Disintegrating Tablets of Standardized <i>Rhodiola rosea</i> Extract.","authors":"Oxana Brante, Rihards Talivaldis Bagons, Santa Niedra, Austris Mazurs, Baiba Mauriņa, Jurga Bernatoniene, Konstantins Logviss","doi":"10.3390/ph18091328","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives:</b><i>Rhodiola rosea</i> L. (<i>Crassulaceae</i>), a perennial adaptogenic herb native to Northern Europe, Asia, and North America, is renowned for its therapeutic properties attributed to phenolic compounds including flavonoids, phenylethanoids, phenylpropanoids, and cinnamyl alcohol glycosides. The plant's antioxidant and anti-inflammatory activities align with its traditional use in boosting physical and cognitive performance, reducing fatigue, and improving stress resilience. However, conventional dosage forms present compliance challenges, particularly for vulnerable populations with swallowing difficulties. This study aimed to develop and optimize orally disintegrating tablets (ODTs) containing standardized <i>Rhodiola rosea</i> root and rhizome (<i>RR</i>) dry extract to ensure rapid disintegration and acceptable taste, thereby improving patient compliance. <b>Methods:</b> Dried <i>Rhodiola rosea</i> root and rhizome (particle size 2-3 mm) were extracted using 70% m/m ethanol using the fractionated maceration methodology. The resulting dry <i>RR</i> extract was standardized to 3.0% m/m rosavin content by blending batches of the extract and analyzed using validated chromatographic methods. The standardized dry extract was formulated into ODTs via direct compression technology. Various excipients were evaluated to achieve rapid disintegration while masking the characteristic bitter taste of <i>RR</i> extract. <b>Results:</b> The optimized ODT formulation (500 mg, 11 mm ø, 20% standardized <i>RR</i> dry extract) disintegrated within 3 min and effectively masking the characteristic bitterness of the <i>RR</i> extract. The formulation maintained content uniformity and did not exhibit loss of active compounds during processing, meeting European Pharmacopoeia requirements for ODTs. <b>Conclusions:</b> The developed ODTs containing standardized <i>Rhodiola rosea</i> extract offer a patient-friendly alternative for oro-mucosal administration, supporting improved compliance in populations with swallowing difficulties while retaining the extract's phytochemical integrity and sensory acceptability.</p>","PeriodicalId":20198,"journal":{"name":"Pharmaceuticals","volume":"18 9","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12472554/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/ph18091328","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives:Rhodiola rosea L. (Crassulaceae), a perennial adaptogenic herb native to Northern Europe, Asia, and North America, is renowned for its therapeutic properties attributed to phenolic compounds including flavonoids, phenylethanoids, phenylpropanoids, and cinnamyl alcohol glycosides. The plant's antioxidant and anti-inflammatory activities align with its traditional use in boosting physical and cognitive performance, reducing fatigue, and improving stress resilience. However, conventional dosage forms present compliance challenges, particularly for vulnerable populations with swallowing difficulties. This study aimed to develop and optimize orally disintegrating tablets (ODTs) containing standardized Rhodiola rosea root and rhizome (RR) dry extract to ensure rapid disintegration and acceptable taste, thereby improving patient compliance. Methods: Dried Rhodiola rosea root and rhizome (particle size 2-3 mm) were extracted using 70% m/m ethanol using the fractionated maceration methodology. The resulting dry RR extract was standardized to 3.0% m/m rosavin content by blending batches of the extract and analyzed using validated chromatographic methods. The standardized dry extract was formulated into ODTs via direct compression technology. Various excipients were evaluated to achieve rapid disintegration while masking the characteristic bitter taste of RR extract. Results: The optimized ODT formulation (500 mg, 11 mm ø, 20% standardized RR dry extract) disintegrated within 3 min and effectively masking the characteristic bitterness of the RR extract. The formulation maintained content uniformity and did not exhibit loss of active compounds during processing, meeting European Pharmacopoeia requirements for ODTs. Conclusions: The developed ODTs containing standardized Rhodiola rosea extract offer a patient-friendly alternative for oro-mucosal administration, supporting improved compliance in populations with swallowing difficulties while retaining the extract's phytochemical integrity and sensory acceptability.

标准红景天提取物口腔崩解片的研制。
背景/目的:红景天是一种原产于北欧、亚洲和北美的多年生适应原草本植物,因其含有类黄酮、苯乙醇、苯丙素和肉桂醇苷等酚类化合物而闻名。这种植物的抗氧化和抗炎活性与它在提高身体和认知能力、减轻疲劳和提高压力恢复能力方面的传统用途一致。然而,传统的剂型存在依从性挑战,特别是对于吞咽困难的易感人群。本研究旨在开发和优化含有标准红景天根茎干提取物的口腔崩解片(ODTs),以保证快速崩解和可接受的口感,从而提高患者的依从性。方法:采用分馏浸渍法,采用70% m/m乙醇提取干燥的红景天根和根茎(粒径2 ~ 3 mm)。将萃取物混合批次后得到的干RR萃取物标准化为3.0% m/m的蔷薇素含量,并使用经过验证的色谱方法进行分析。通过直接压缩技术将标准干提取物配制成odt。评估了各种赋形剂,以实现快速崩解,同时掩盖RR提取物的特征苦味。结果:优化后的ODT配方(500 mg, 11 mm ø, 20%标准RR干提取物)在3 min内崩解,有效掩盖了RR提取物的特征苦味。该制剂在加工过程中保持了含量的均匀性,没有表现出活性成分的损失,符合欧洲药典对odt的要求。结论:开发的含有标准红景天提取物的odt为口腔粘膜给药提供了一种患者友好的选择,支持吞咽困难人群的依从性,同时保留提取物的植物化学完整性和感官可接受性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceuticals
Pharmaceuticals Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
6.10
自引率
4.30%
发文量
1332
审稿时长
6 weeks
期刊介绍: Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of medicinal chemistry and related drug sciences.Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details. Short communications are also accepted; therefore, there is no restriction on the maximum length of the papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信